Delivery Order SPE2DB22D3011-SPE2DB24FQ3EH
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,644.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the NEUPOGEN 300 MCG/ML VIALML product, with a firm fixed price and an ultimate completion date of June 11, 2025. AmerisourceBergen Drug Corp, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NEUPOGEN 300 MCG/ML VIALML pharmaceutical products. The contract, valued at $8,527.28, was awarded by the Defense Logistics Agency (DLA), a defense agency, on April 15, 2024 with a completion date of April 16, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen, a major pharmaceutical...
This federal contract award, valued at $1,214.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of NEUPOGEN 300 MCG/ML VIALML, a medical product, with a firm fixed price and an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of NEUPOGEN 480 MCG/0.8 ML SYR 0.8ML, a specialty pharmaceutical product. The contract has a firm fixed price of $17,160.11 and a period of performance through November 14, 2024. Amerisourcebergen is a major pharmaceutical distribution and healthcare solutions provider, and this contract is part of the company's broader Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency awarded a Firm Fixed Price delivery order contract valued at $2,303.34 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of NEUPOGEN 300 MCG/ML VIALML pharmaceutical products to support federal government medical requirements. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support...
This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Neupogen 480 mcg/0.8 mL syringes. The contract is a firm-fixed-price delivery order with a ceiling value of $4,019.12 and a performance period through June 23, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that serves as a comprehensive global...
This federal contract award is for the delivery of Epogen 20,000 units/2 ml vials, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,742.18 firm-fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, with ID SPE2DX15D1022|SPE2DX24FVNTN, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The $28,909.05 firm-fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML pharmaceutical products, with a period of performance through September 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by the...
This federal contract award, valued at $1,212.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566325041 ! CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a completion date of November 5, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism. It is not designated as a set-aside contract. Amerisourcebergen...